Latest news with #Promino
Yahoo
06-05-2025
- Business
- Yahoo
Promino Expands Fastbreak Partnership, Activates at The Penn Relays and Key Summer Competitions
"Promino is doubling down on what we believe is one of the most powerful marketing channels: youth sports," added John Stewart, CEO of Fastbreak AI. "Fastbreak Connect gives brands a way to build meaningful relationships and activate in a space that cuts through the noise of traditional marketing. The results Promino has driven, both in sales and engagement, are a testament to their vision. They recognized early on that youth sports aren't just another weekend activity, they're a brand loyalty engine." Fastbreak Connect, the AI-driven platform behind the partnership, enables brands to seamlessly activate live experiences at high-traffic youth sports events and provides actionable data on sampling and consumer engagement. Used by global brands, Fastbreak Connect reaches over 850,000 youth athletes annually and powers activations at more than 10,000 tournaments across the United States. "Our initial Fastbreak events exceeded our expectations, kickstarting Promino's direct-to-consumer business with meaningful increases in traffic and sales," said Vito Sanzone, CEO of Promino. "Promino patented protein drink has low calories, no sugar, no dairy and is fully plant-based. These attributes and our taste profile make Promino an obvious choice for all athletes, which is why we align with Fastbreak AI for live sampling and the technology platform to drive same-day sales." The Penn Relays draws more than 120,000 athletes, coaches, and parents from across the country, offering Promino™ - NSF Certified for Sport® a unique opportunity to connect directly with a national base of youth and collegiate athletes. This is the first of five Fastbreak-organized events Promino will participate in throughout the spring and summer of 2025, with additional opportunities being considered based on performance. Burlington, Ontario--(Newsfile Corp. - May 6, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce it is extending its successful partnership with Fastbreak AI through summer 2025. Following a surge in direct-to-consumer sales and audience engagement from February's round one activations, Promino will now continue to offer sampling at major athletic showcases including the just concluded Penn Relays. Story Continues About The Penn Relays The Penn Relays, hosted annually by the University of Pennsylvania since 1895, is the oldest and largest track and field competition in the United States. It brings together more than 15,000 participants and over 120,000 spectators for three days of high-level competition and community celebration, making it a premier platform for sports brand activations. About Fastbreak AI Fastbreak AI delivers the leading artificial intelligence platform for tournament operations, brand activations, and sponsorship optimization. Its Fastbreak Connect program allows brands to engage youth athletes and families through turnkey sampling campaigns backed by real-time performance analytics. Visit to learn more. About Promino Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle™ Activator, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario. For more information about Rejuvenate Muscle™ Activator and where to purchase, visit Promino™ - NSF Certified for Sport® brand ambassadors include NHL Stanley Cup™ Champion Jack Eichel of the Vegas Golden Knights and MLB Legend and Toronto Blue Jays 6x All-Star José Bautista. To learn more about Promino, visit Forward-Looking Statements This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's business prospects, potential growth in the functional beverage market, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. For further information about Promino: Vito Sanzone, CEO, vsanzone@ 289-348-1970 ext. 222 Marc Charbin, Investor Relations, 416-467-5229 To view the source version of this press release, please visit
Yahoo
17-04-2025
- Business
- Yahoo
Promino Nutritional Sciences Inc. Announces that Promino(TM) Named Official Protein Drink of the Vegas Knight Hawks
Expanding U.S. sports presence as brand aligns with Las Vegas franchises Burlington, Ontario--(Newsfile Corp. - April 17, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino"), a Canadian leader in muscle health and functional performance beverages, is pleased to announce that its flagship product Promino™ - NSF Certified for Sport® has been named the Official Protein Drink of the Vegas Knight Hawks, a professional Indoor Football League team based in Las Vegas, Nevada. This partnership, executed on April 15, 2025, represents a significant milestone in Promino's U.S. expansion strategy and strengthens its position in one of America's fastest-growing sports markets. The Vegas Knight Hawks join a growing roster of Promino-affiliated teams and athletes in the Las Vegas market, including Team Promino athlete José Bautista's Las Vegas Lights FC and Vegas Golden Knights superstar Jack Eichel, who officially joined Team Promino in 2024. "Las Vegas is more than just a sports town — it's where culture, performance, and visibility collide," said Vito Sanzone, CEO of Promino. "Our partnerships here are foundational to Promino's functional beverage strategy in the U.S. The energy of this city, and the caliber of its athletes and fans, align perfectly with our mission to redefine recovery and performance nutrition. Las Vegas is a proving ground, and we intend to win here." "We're excited to welcome Promino as the Official Protein Drink of the Vegas Knight Hawks," said Gabe Mirabelli, Chief Business Officer of FEG Minor League Sports Properties. "Their focus on innovation and performance nutrition is a natural fit for our team, and we look forward to building this partnership on and off the field." Promino™ is a clinically validated muscle activator designed to enhance muscle recovery, strength, and function without the use of traditional dairy-based proteins. The brand will be featured in-arena, across digital campaigns, and within team training environments. About The Vegas Knight Hawks The Vegas Knight Hawks are an Indoor Football League franchise operated by the Foley Entertainment Group. The Knight Hawks play their home games at Lee's Family Forum in Henderson, NV. For the latest news and information on the Knight Hawks visit Fans can follow the team on Facebook, Twitter and Instagram. About Promino Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle™ Activator, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario. For more information about Rejuvenate Muscle™ Activator and where to purchase, visit Promino™ - NSF Certified for Sport® brand ambassadors include NHL Stanley Cup™ Champion Jack Eichel of the Vegas Golden Knights and MLB Legend and Toronto Blue Jays 6x All-Star José Bautista. To learn more about Promino, visit Forward-Looking Statements This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's business prospects, potential growth in the functional beverage market, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. For further information about Promino: Vito Sanzone, CEO, vsanzone@ 289-348-1970 ext. 222 Marc Charbin, Investor Relations, 416-467-5229 To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
14-04-2025
- Health
- Yahoo
Promino Nutritional Sciences Inc. Launches Second Preclinical Study Targeting Reduction of Muscle Loss in Breast and Prostate Cancer Patients Undergoing Chemotherapy
Research to explore Promino's patented amino acid blend in addressing treatment-related muscle wasting in two of the most prevalent cancers among women and men Study led by Dr. Patrick Gunning, Professor of Medicinal Chemistry and Molecular Therapeutics, University of Toronto and University of Glasgow Burlington, Ontario--(Newsfile Corp. - April 14, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce the launch of its second round of preclinical studies evaluating the effects of Promino, a patented essential amino acid (EAA) blend, on muscle preservation and systemic health during chemotherapy treatment for breast and prostate cancer - the most commonly diagnosed cancers in women and men, respectively. The preclinical trials will be conducted using murine models and aim to provide critical insights into the role of Promino's clinically formulated EAA blend in counteracting the severe muscle loss (cachexia) often associated with chemotherapy. The studies are being led by Dr. Patrick Gunning, a globally recognized medicinal chemist and Chief Scientific Advisor to Promino. Addressing a Widespread and Underserved Need in Oncology Support Breast cancer affects more than 2.3 million women globally each year[1], while prostate cancer impacts over 1.4 million men annually[2]. Despite advances in oncology, many patients suffer significant declines in muscle mass and function during chemotherapy, impairing both treatment tolerance and recovery outcomes. "These preclinical studies represent a critical step toward understanding how targeted amino acid formulations can support patients undergoing highly demanding chemotherapy protocols," said Dr. Patrick Gunning, Chief Scientific Advisor to Promino. "Preserving muscle mass and function is not only about quality of life, it may also influence treatment outcomes and recovery trajectories. We're excited to be advancing this vital research." Rooted in Breakthrough Science by Leading Researchers Promino's formulation was developed by Dr. Robert Wolfe of the University of Arkansas, leaders in amino acid science and pioneers in the study of muscle metabolism. Their patented EAA blend is optimized to stimulate muscle protein synthesis, even in the face of metabolic stress such as surgical recovery and extreme metabolic deficit. Toward a Dedicated Oncology Line for Patients and Providers This latest preclinical initiative will not only help inform Promino's future clinical roadmap but also support the development of a Promino line specifically tailored to oncology care with the goal of providing patients, healthcare systems, and medical professionals with targeted nutritional tools to help combat treatment-related muscle wasting. "This is a landmark moment for Promino and the science behind our proprietary amino acid blend," said Vito Sanzone, CEO of Promino. "We are uniquely positioned to lead the intersection of clinical nutrition and cancer care. Our goal is to deliver Promino as a precision nutritional therapy that supports better treatment tolerance, faster recovery, and stronger quality of life." Next Steps The new preclinical studies follow encouraging initial data and are designed to meet rigorous scientific standards. Results will inform future human trials and potential clinical collaborations with leading oncology institutions in North America. For more information on Promino's research pipeline and commitment to innovation in clinical nutrition, visit About Promino Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle™ Activator, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario. For more information about Rejuvenate Muscle™ Activator and where to purchase, visit Promino™ - NSF Certified for Sport® brand ambassadors include NHL Stanley Cup™ Champion Jack Eichel of the Vegas Golden Knights and MLB Legend and Toronto Blue Jays 6x All-Star José Bautista. To learn more about Promino, visit Forward-Looking Statements This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's business prospects, potential growth in the functional beverage market, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. For further information about Promino: Vito Sanzone, CEO, vsanzone@ 289-348-1970 ext. 222 Marc Charbin, Investor Relations, 416-467-5229 [1] Current and future burden of breast cancer: Global statistics for 2020 and 2040 - PMC[2] The Lancet Commission on prostate cancer: planning for the surge in cases - The Lancet To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
03-04-2025
- Business
- Yahoo
Promino Nutritional Sciences Inc. Reports Q1 2025 Revenue from the Amazon.com Platform
Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is thrilled to report revenue through increasing from US$1,500 in December 2024 to US$99,700 in the first calendar quarter of 2025. This represents at 36x increase from December 2024 to March 2025 for Promino's two plant-based protein muscle health products. Promino's sales over the platform reinitiated in December 2024, beginning with Rejuvenate Muscle™ Activator. In February 2025, Promino™ – NSF Certified for Sport® sales were reinitiated. Not only do sales on the platform provide contribution margin for the Company, other retailers use data from this platform to assess listings of new products. Promino believes it is still in its infancy with respect to potential revenue though Revenue over in the last four months was as follows: December 2024: US$1,500 January 2025: US$9,500 February 2025: US$35,200 March 2025: US$55,000 The Company expects to generate a gross margin of approximately 60% from this revenue. This surge in revenue is driven by growing consumer demand for Promino's plant-based protein muscle health innovations, particularly: Rejuvenate Muscle™ Activator: Now leading the product portfolio with over 1,600 units sold monthly, showing consistent week-over-week sales growth. Promino™ – NSF Certified for Sport®: The Company's flagship premium sports nutrition offering is gaining traction with over 100 units sold per month, quickly becoming a trusted choice among athletes and fitness professionals. "These results reflect Promino's increasing relevance in the active lifestyle and healthy aging markets," said Vito Sanzone, CEO of Promino. "Rejuvenate is clearly resonating with consumers seeking strength and recovery solutions, and our Promino NSF™ Certified for Sport® product, with the support of NHL superstar Jack Eichel and MLB legend Jose Bautista, is carving out a strong position with performance-focused users." The Company credits its early 2025 success to strategic investments in digital marketing, a national high school athletics sampling program, and rapidly growing consumer trust in its patented, science-backed formulations. About Promino Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle™ Activator, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario. For more information about Rejuvenate Muscle™ Activator and where to purchase, visit Promino™ - NSF Certified for Sport® brand ambassadors include NHL Stanley Cup™ Champion Jack Eichel of the Vegas Golden Knights and MLB Legend and Toronto Blue Jays 6x All-Star José Bautista. To learn more about Promino, visit Forward-Looking Statements This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's business prospects, expected gross margin, potential growth in the functional beverage market, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors. This press release contains financial outlook disclosure about the Company's anticipated gross margin in respect of its Amazon-originated revenue, which is subject to the same assumptions, risk factors, limitations and qualifications as set forth in the above paragraphs. The financial outlook contained in this press release was made as of the date of this press release and was provided for the purpose of providing further information about the Company's anticipated future business operations. Readers are cautioned that the financial outlook contained in this press release should not be used for purposes other than for which it is disclosed herein. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. For further information about Promino:Vito Sanzone, CEO, vsanzone@ 289-348-1970 ext. 222 Marc Charbin, Investor Relations, 416-467-5229 To view the source version of this press release, please visit Sign in to access your portfolio
Yahoo
03-03-2025
- Business
- Yahoo
Promino Nutritional Sciences Inc. Announces Research Supporting Efficacy of Promino(TM): One Serving is Equivalent to 75 Grams of Whey Protein in Stimulating Muscle Protein Synthesis
Burlington, Ontario--(Newsfile Corp. - March 3, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") announces today that it has established that one serving of its patented Promino™ - NSF Certified for Sport® formula is equivalent to 75 grams of whey protein in stimulating muscle protein synthesis ("MPS"). Promino™ offers athletes and fitness enthusiasts a more efficient, bioavailable, and digestion-friendly alternative to traditional protein supplementation. Promino™ is available at Why Promino™ Stimulates Greater Muscle Protein Synthesis While whey protein has long been a staple in muscle recovery, research indicates that its efficacy declines beyond a 40g serving1. Studies show that MPS plateaus at approximately 20g to 25g of whey protein per serving, with only marginal benefits seen up to 40g. Beyond this threshold, excess whey is not fully utilized for muscle growth and may be converted to waste or fat. Furthermore, few clinical studies have explored the effects of whey protein at servings greater than 40g, making it difficult to quantify its impact beyond this range. However, based on existing data1, the efficiency of 40g of whey protein can be extrapolated to higher doses using mathematical models, allowing the Company to confidently determine that one serving of Promino™ delivers the same muscle-building benefits as 75g of whey protein. Promino™ achieves this superior efficiency by leveraging a precision-engineered Essential Amino Acid ("EAA") formulation that delivers optimal ratios of leucine and other EAAs to maximize MPS with minimal waste. Unlike whey, which contains a mix of unnecessary non-essential amino acids, Promino™ provides only what the body needs to consume for muscle growth, ensuring every gram is effectively utilized. Elite Athletes Trust Promino™ Promino™ is backed by some of the most elite athletes in professional sports, including: Jose Bautista - former professional baseball player and current owner of the USL Las Vegas Lights Jack Eichel - professional hockey player, currently with the Las Vegas Golden Knights Kirk McLean - former professional hockey player, former goalie of the Vancouver Canucks These athletes rely on Promino™ to enhance performance, accelerate recovery, and optimize muscle protein synthesis, demonstrating the formula's effectiveness at the highest levels of competition. Revolutionizing Sports Nutrition "This announcement represents a new alternative in sports nutrition," said Vito Sanzone, Chief Executive Officer. "For years, athletes have been consuming large amounts of whey protein without understanding its limitations. With Promino™, we offer a clinically validated, NSF Certified for Sport® solution that delivers superior muscle support with far less volume and zero digestive discomfort." About Promino Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle™ Activator, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario. For more information about Rejuvenate Muscle™ Activator and where to purchase, visit Promino™ - NSF Certified for Sport® brand ambassadors include NHL Stanley Cup™ Champion Jack Eichel of the Vegas Golden Knights and MLB Legend and Toronto Blue Jays 6x All-Star José Bautista. To learn more about Promino, visit Forward-Looking Statements This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's business prospects, potential growth in the functional beverage market, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. For further information about Promino: Vito Sanzone, CEO, vsanzone@ 289-348-1970 ext. 222 Marc Charbin, Investor Relations, 416-467-5229 1 Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006 Sep; Wolfe RR, Rutherfurd SM, Kim IY, Moughan PJ. Protein quality as determined by the Digestible Indispensable Amino Acid Score: evaluation of factors underlying the calculation; Oikawa SY, Kamal MJ, Webb EK, McGlory C, Baker SK, Phillips SM. Whey protein but not collagen peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in healthy older women: a randomized controlled trial. Am J Clin Nutr. 2020 Mar 1; Church DD, Ferrando AA, Wolfe RR. Stimulation of muscle protein synthesis with low-dose amino acid composition in older individuals. Front Nutr. 2024 Mar 8; Paddon-Jones D, Sheffield-Moore M, Katsanos CS, Zhang XJ, Wolfe RR. Differential stimulation of muscle protein synthesis in elderly humans following isocaloric ingestion of amino acids or whey protein. Exp Gerontol. 2006 Feb; Witard OC, Jackman SR, Breen L, Smith K, Selby A, Tipton KD. Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise. Am J Clin Nutr. 2014 Jan; and Børsheim E, Bui QT, Tissier S, Kobayashi H, Ferrando AA, Wolfe RR. Effect of Amino Acid Supplementation on Muscle Mass, Strength and Physical Function in Elderly. Clin Nutr. 2008 Apr. To view the source version of this press release, please visit Sign in to access your portfolio
